Literature DB >> 9039514

Development of systemic lupus erythematosus in a patient with selective complete C1q deficiency.

A I Berkel1, F Petry, O Sanal, K Tinaztepe, F Ersoy, A Bakkaloglu, M Loos.   

Abstract

UNLABELLED: A 7-year-old male with recurrent erythematous and desquamated skin lesions and respiratory infections was diagnosed as selective complete C1q deficiency following detailed studies of the complement system. His asymptomatic sister also had selective complete C1q deficiency. During a follow up period of 3 years, his skin lesions persisted, he suffered from recurrent bronchopneumonias and glomerulonephritis developed. Renal function deteriorated with the appearance of anti-DNA antibodies. Renal biopsy was consistent with systemic lupus erythematosus. The patient was treated with immunosuppressive drugs, but died of renal failure. It is postulated that in this patient defective clearance of antigen-antibody complexes by the reticulo-endothelial system resulted in progressive renal disease as observed in other complement deficiencies. A retrospective molecular study disclosed a point mutation in the ClqA chain gene in a heterozygous state in parents and two siblings; in a homozygous state in the asymptomatic sister. The reason why some individuals with this defect are asymptomatic is not known at present. Diagnosis of heterozygotes by molecular studies is extremely important to give genetic counselling to the family.
CONCLUSION: Patients with recurrent infections, erythematous desquamative skin lesions, malar rash and oral mucosal involvement should be screened for complement C1q deficiency.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9039514     DOI: 10.1007/s004310050567

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  5 in total

Review 1.  [Lupus erythematosus. Wide range of symptoms through clinical variation, associated diseases and imitators].

Authors:  E Aberer
Journal:  Hautarzt       Date:  2010-08       Impact factor: 0.751

2.  C1q complement component and -antibodies reflect SLE activity and kidney involvement.

Authors:  P Horák; Z Hermanová; J Zadrazil; H Ciferská; M Ordeltová; L Kusá; M Zurek; T Tichý
Journal:  Clin Rheumatol       Date:  2005-11-26       Impact factor: 2.980

3.  Recurrent pneumococcal meningitis in homozygous C3 deficiency.

Authors:  Mehmet Totan
Journal:  Indian J Pediatr       Date:  2002-07       Impact factor: 1.967

Review 4.  Early Components of the Complement Classical Activation Pathway in Human Systemic Autoimmune Diseases.

Authors:  Katherine E Lintner; Yee Ling Wu; Yan Yang; Charles H Spencer; Georges Hauptmann; Lee A Hebert; John P Atkinson; C Yung Yu
Journal:  Front Immunol       Date:  2016-02-15       Impact factor: 7.561

5.  Extensive ulcerations due to pyoderma gangrenosum in a child with juvenile systemic lupus erythematosus and C1q deficiency.

Authors:  Abanomi Hind; Al-Ghamdi Abdulmonem; Sulaiman Al-Mayouf
Journal:  Ann Saudi Med       Date:  2008 Nov-Dec       Impact factor: 1.526

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.